The DOI matches its Crossref record.
Association of cerebrospinal fluid anti–NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus
Abstract
Objective: To explore the association of antibodies directed against N‐methyl‐D‐aspartate receptor subunit NR2 (anti‐NR2) in cerebrospinal fluid (CSF) with neuropsychiatric manifestations in systemic lupus erythematosus (NPSLE). Methods: Paired serum and CSF specimens were obtained from 56 patients with NPSLE (38 with diffuse psychiatric/neuropsychological syndromes [diffuse NPSLE] and 18 with neurologic syndromes or peripheral neuropathy [focal NPSLE]) and from 20 control patients with noninflammatory neurologic diseases. IgG anti‐NR2 antibodies were measured by enzyme‐linked immunosorbent assay using synthetic peptide containing the extracellular ligand‐binding domain of NR2. The binding of affinity‐purified anti‐NR2 to human neuroblastoma cell line SK‐N‐MC was examined by flow cytometry. Results: Purified anti‐NR2 bound to the surface of SK‐N‐MC cells. Levels of anti‐NR2 antibodies in CSF were significantly elevated in patients with diffuse NPSLE compared with levels in control patients or those with focal NPSLE, whereas there were no significant differences in serum anti‐NR2 levels among the 3 groups. In 31 of the 38 patients with diffuse NPSLE (81.6%) and 8 of the 18 patients with focal NPSLE (44.4%), CSF anti‐NR2 levels were more than 3 SD above the mean level in the control patients (P = 0.0120 by chi‐square test). Conclusion: These results indicate that anti‐NR2 is a constituent of antineuronal antibodies and, more importantly, that anti‐NR2 antibodies in CSF, but not in serum, are associated with diffuse NPSLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Neuropsychiatric lupus: new mechanistic insights and future treatment directions
Schwartz, N., Stock, A. D., & Putterman, C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0156-8 · Cited by 429
Diagnosis and management of neuropsychiatric SLE
Hanly, J. G. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.15 · Cited by 290
Role of Inflammation in Suicide: From Mechanisms to Treatment
Brundin, L., Bryleva, E. Y., & Thirtamara Rajamani, K. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.116 · Cited by 257
“Interestingly, the presence of anti-NR1 antibodies has been consistently reported in the CSF of SLE patients and correlates positively with their neuropsychiatric symptoms (Arinuma et al , 2008; Fragoso-Loyo et al , 2008; Gono et al , 2011; Lapteva et al , 2006; Yoshio et al , 2006).”
Metadata
- Authors
- Arinuma, Y., Yanagida, T., & Hirohata, S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2008-03-27
- Volume
- 58
- Issue
- 4
- Pages
- 1130-1135
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2001953810
- Cited by
- 252
- References
- 0
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of cerebrospinal fluid anti–NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. https://app.cochat.ai/papers/10.1002/art.23399
- The paper
- Arinuma, Y., Yanagida, T., & Hirohata, S. (2008). Association of cerebrospinal fluid anti–NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis & Rheumatism. https://doi.org/10.1002/art.23399
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.